Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-20

Clinical Trial Update: Dose Finding Study of Pioglitazone in Children With Autism Spectrum Disorders (ASD) (PIO) [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding clinical trial of pioglitazone in children with autism spectrum disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Evdokia Anagnostou | Conditions: Autism Spectrum Disorders | Phase 2 | Status: COMPLETED